Advisory Council on Alzheimer's Research, Care, and Services; Meeting, 104 [2021-28412]

Download as PDF 104 Federal Register / Vol. 87, No. 1 / Monday, January 3, 2022 / Notices HRSA specifically requests comments on: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2021–28414 Filed 12–30–21; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Advisory Council on Alzheimer’s Research, Care, and Services; Meeting Assistant Secretary for Planning and Evaluation, HHS. ACTION: Notice of meeting. AGENCY: This notice announces the public meeting of the Advisory Council on Alzheimer’s Research, Care, and Services (Advisory Council). The Advisory Council provides advice on how to prevent or reduce the burden of Alzheimer’s disease and related dementias on people with the disease and their caregivers. During the January 24, 2022 meeting the Advisory Council will hear about the National Plan to Address Alzheimer’s Disease: 2021 Update, as well as update from federal agencies. The Advisory Council will also hear presentations about dementia risk reduction for veterans and research on the potential relationship between COVID–19 and dementia. The Advisory Council will also hear about a recent report on the current capacity of the dementia care workforce. A panel will present on dementia assessment tools for special populations, such as individuals with intellectual and developmental disabilities. Finally, the Advisory Council will hear from a panel on the inclusion of caregivers in clinical care settings, including those in rural communities. DATES: The meeting will be held on January 24, 2022 from 12:00 p.m. to 4:30 p.m. EST. ADDRESSES: The meeting will be virtual, streaming live at www.hhs.gov/live. Comments: Time is allocated on the agenda to hear public comments from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited to two (2) minutes per individual. In order to provide a public comment, please khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:14 Dec 30, 2021 Jkt 256001 register by emailing your name to napa@hhs.gov by Thursday, January 20. On Friday, January 21, registered commenters will receive both a dial-in number and a link to join the meeting virtually; individuals will have the choice to either join virtually via the link, or to call in only by using the dialin number. Note: There may be a 30–45 second delay in the livestream video presentation of the conference. For this reason, if you have pre-registered to submit a public comment, it is important to connect to the meeting by 3:45 p.m. to ensure that you do not miss your name and allotted time when called. If you miss your name and allotted time to speak, you may not be able to make your public comment. All participant audio lines will be muted for the duration of the meeting and only unmuted by the Host at the time of the participant’s public comment. Should you have questions during the session email napa@hhs.gov and someone will respond to your message as quickly as possible. In order to ensure accuracy, please submit a written copy of oral comments for the record by emailing napa@ hhs.gov by Tuesday, January 25. These comments will be shared on the website and reflected in the meeting minutes. In lieu of oral comments, formal written comments may be submitted for the record by Tuesday, January 25 to Helen Lamont, Ph.D., OASPE, 200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments may also be sent to napa@hhs.gov. Those submitting written comments should identify themselves and any relevant organizational affiliations. FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202–260–6075, helen.lamont@hhs.gov. Note: The meeting will be available to the public live at www.hhs.gov/live. SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and (a)(2)). Topics of the Meeting: Long-term services and supports workforce, caregiving. Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer’s Project Act website when available, after the meeting. Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National Alzheimer’s Project Act. The panel is governed by provisions of Public Law 92–463, as amended (5 U.S.C. Appendix 2), which sets forth standards for the formation and use of advisory committees. PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Dated: December 22, 2021. Benjamin Sommers, Deputy Assistant Secretary for Planning and Evaluation Acting on Behalf of Rebecca Haffajee, Acting Assistant Secretary for Planning and Evaluation. [FR Doc. 2021–28412 Filed 12–30–21; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Genetic Variant-based Drug Development for Healthy Aging. Date: March 2, 2022. Time: 11:30 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting). Contact Person: Alexander Parsadanian, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building 2C/212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, parsadaniana@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; Glial Pathology in Brain Aging. Date: March 11, 2022. Time: 12:00 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Video Meeting). Contact Person: Alexander Parsadanian, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, National Institutes of Health, Gateway Building 2C/212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, parsadaniana@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) E:\FR\FM\03JAN1.SGM 03JAN1

Agencies

[Federal Register Volume 87, Number 1 (Monday, January 3, 2022)]
[Notices]
[Page 104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28412]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Advisory Council on Alzheimer's Research, Care, and Services; 
Meeting

AGENCY: Assistant Secretary for Planning and Evaluation, HHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces the public meeting of the Advisory 
Council on Alzheimer's Research, Care, and Services (Advisory Council). 
The Advisory Council provides advice on how to prevent or reduce the 
burden of Alzheimer's disease and related dementias on people with the 
disease and their caregivers. During the January 24, 2022 meeting the 
Advisory Council will hear about the National Plan to Address 
Alzheimer's Disease: 2021 Update, as well as update from federal 
agencies. The Advisory Council will also hear presentations about 
dementia risk reduction for veterans and research on the potential 
relationship between COVID-19 and dementia. The Advisory Council will 
also hear about a recent report on the current capacity of the dementia 
care workforce. A panel will present on dementia assessment tools for 
special populations, such as individuals with intellectual and 
developmental disabilities. Finally, the Advisory Council will hear 
from a panel on the inclusion of caregivers in clinical care settings, 
including those in rural communities.

DATES: The meeting will be held on January 24, 2022 from 12:00 p.m. to 
4:30 p.m. EST.

ADDRESSES: The meeting will be virtual, streaming live at www.hhs.gov/live.
    Comments: Time is allocated on the agenda to hear public comments 
from 4:00 p.m. to 4:30 p.m. The time for oral comments will be limited 
to two (2) minutes per individual. In order to provide a public 
comment, please register by emailing your name to [email protected] by 
Thursday, January 20. On Friday, January 21, registered commenters will 
receive both a dial-in number and a link to join the meeting virtually; 
individuals will have the choice to either join virtually via the link, 
or to call in only by using the dial-in number. Note: There may be a 
30-45 second delay in the livestream video presentation of the 
conference. For this reason, if you have pre-registered to submit a 
public comment, it is important to connect to the meeting by 3:45 p.m. 
to ensure that you do not miss your name and allotted time when called. 
If you miss your name and allotted time to speak, you may not be able 
to make your public comment. All participant audio lines will be muted 
for the duration of the meeting and only unmuted by the Host at the 
time of the participant's public comment. Should you have questions 
during the session email [email protected] and someone will respond to your 
message as quickly as possible.
    In order to ensure accuracy, please submit a written copy of oral 
comments for the record by emailing [email protected] by Tuesday, January 
25. These comments will be shared on the website and reflected in the 
meeting minutes.
    In lieu of oral comments, formal written comments may be submitted 
for the record by Tuesday, January 25 to Helen Lamont, Ph.D., OASPE, 
200 Independence Avenue SW, Room 424E, Washington, DC 20201. Comments 
may also be sent to [email protected]. Those submitting written comments 
should identify themselves and any relevant organizational 
affiliations.

FOR FURTHER INFORMATION CONTACT: Helen Lamont, 202-260-6075, 
[email protected]. Note: The meeting will be available to the public 
live at www.hhs.gov/live.

SUPPLEMENTARY INFORMATION: Notice of these meetings is given under the 
Federal Advisory Committee Act (5 U.S.C. App. 2, section 10(a)(1) and 
(a)(2)). Topics of the Meeting: Long-term services and supports 
workforce, caregiving.
    Procedure and Agenda: The meeting will be webcast at www.hhs.gov/live and video recordings will be added to the National Alzheimer's 
Project Act website when available, after the meeting.
    Authority: 42 U.S.C. 11225; Section 2(e)(3) of the National 
Alzheimer's Project Act. The panel is governed by provisions of Public 
Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth 
standards for the formation and use of advisory committees.

    Dated: December 22, 2021.
Benjamin Sommers,
Deputy Assistant Secretary for Planning and Evaluation Acting on Behalf 
of Rebecca Haffajee, Acting Assistant Secretary for Planning and 
Evaluation.
[FR Doc. 2021-28412 Filed 12-30-21; 8:45 am]
BILLING CODE 4150-05-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.